You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

À propos des lignes directrices

Displaying Guidelines

17 articles

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Document Status: Current
ID: GL 2-33
Version: 2

Updated

Jun 2025

Systemic Treatment Emergency Preparedness Guidance Document

Document Status: Current

Updated

Aug 2025

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Document Status: Current

Mar 2025

The Use of Indoor Tanning Devices and the Risk of Developing Cutaneous Malignant Melanoma: A Systematic Review and Clinical Practice Guideline

Document Status: Current
ID: 8-8
Version: 2

Updated

Sep 2025

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Document Status: Current
ID: MOTAC-7

Jan 2025